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Abstract 
Introduction: It is well-known that prenatal or postnatal exposure to methylmercury 
can produce neurological signs in adults and children, exemplified by a case of 
large-scale poisoning in Minamata, Japan, in the 1950s. However, evidence regarding 
whether pre- or postnatal exposure to methylmercury causes psychiatric symptoms (e.g., 5 
impairment of intelligence and mood and behavioral dysfunction) is still 
limited—excluding cases of fetal Minamata disease patients.  
Methods: We evaluated the effects of pre- or postnatal exposure to methylmercury on 
psychiatric symptoms using data derived from a 1971 population-based survey in 
Minamata and neighboring communities. We adopted residential areas as an exposure 10 
indicator and psychiatric symptoms as the outcome. Then, we estimated the adjusted 
prevalence odds ratio (POR) and confidence interval (CI) of psychiatric symptoms in 
relation to residential area.  
Results: There were 904 participants in Minamata (high exposure area), 1,700 in 
Goshonoura (middle exposure area), and 913 in Ariake (low exposure area). Compared 15 
to the Ariake area, participants in the Minamata area manifested psychiatric symptoms 
more frequently: PORs for impairment of intelligence and mood and behavioral 
dysfunction were 5.2 (95% CI: 3.7–7.3) and 4.4 (95% CI: 2.9–6.7), respectively. 
Furthermore, participants with psychiatric symptoms in the Minamata area more 
frequently had neurological signs. Peaks in prevalence of psychiatric symptoms 20 
occurred around age 20 and in older age adults in the area. These findings did not 
change when we excluded those who had been officially certified as Minamata disease 
patients by that time.  
Conclusions: The present study suggests a relationship between pre- or postnatal 
exposure to methylmercury and psychiatric symptoms among the general population in 25 
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Minamata even after excluding officially certified patients. 
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1. Introduction 
 It is well-known that prenatal or postnatal exposure to methylmercury can 
cause neurological dysfunction in adults and children (U.S.EPA. 1997). In a large-scale 
poisoning caused by methylmercury in Minamata, Japan, patients manifested 
neurological signs, including ataxia, paresthesia, constriction of the visual field, 5 
dysarthria, and hearing difficulties (Harada 1995; Yorifuji et al. 2008). However, 
evidence regarding whether pre- or postnatal exposure to methylmercury causes 
psychiatric symptoms (e.g., impairment of intelligence or mood and behavioral 
dysfunction) is still limited (Wigle et al. 2008), excluding cases of fetal Minamata 
disease patients (described below) (Harada 1978).  10 
 In Minamata, the patients who were postnatally affected by methylmercury 
were termed “acquired Minamata disease patients”. One case-series study targeting 
acquired Minamata disease patients demonstrated a higher prevalence of psychiatric 
symptoms (impairment of intelligence and mood and behavioral dysfunction) than 
found in non-patients (Inoue 1963). However, none of the epidemiological studies have 15 
quantitatively examined the prevalence of psychiatric symptoms among the general 
population who had postnatal exposure to methylmercury. Indeed, the effect of 
methylmercury on psychiatric symptoms in adults has been seldom recognized in 
reviews (Clarkson et al. 2003; U.S.EPA. 1997). 
 In Minamata, a considerable number of children with conditions resembling 20 
cerebral palsy, so-called “fetal Minamata disease patients”, were born in the affected 
areas (Harada 1978). They were exposed to methylmercury in utero, and it is 
well-known that they manifested psychiatric symptoms such as impairment of 
intelligence and mood and behavioral dysfunction as well as neurological signs and 
motor disturbance (Harada 1964). However, it is still unknown whether residents who 25 
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experienced a more moderate exposure in utero manifested psychiatric symptoms. One 
study reported a higher prevalence of impairment of intelligence among adolescents 
born in the exposed area compared to the non-exposed area from 1955 to 1958 (period 
of high exposure), after excluding fetal Minamata disease patients (Harada and Tajiri 
2009). Another previous study demonstrated that methylmercury concentrations in 5 
umbilical cords in fetal Minamata disease patients as well as in a group of residents with 
impairment of intelligence were higher than in a healthy group (Harada et al. 1999). 
However, studies of this type are scarce. 
 In the present study, we evaluated the effects of pre- or postnatal exposure to 
methylmercury on psychiatric symptoms using data derived from the 1971 10 
population-based survey in Minamata and neighboring communities (Tatetsu et al. 
1972; Yorifuji et al. 2008).  
 
2. Materials and Methods 
2.1. Study Site and Participants 15 
 A brief history of Minamata disease is in order. Severe neurological disorders 
among people living in Minamata (in the southwestern part of Kumamoto Prefecture, 
Japan) were first officially recognized in 1956 (Figure 1) (Harada 1995). After the first 
patient was officially identified in 1956, numerous cases were reported, and the first 
patient with disease was determined to have had it in 1942 (Nishigaki and Harada 1975). 20 
Methylmercury had been produced as a byproduct of acetaldehyde production since 
1932 and was discharged into Minamata Bay (a small part of the Shiranui Sea) from a 
local chemical factory. In 1958, the factory rebuilt its wastewater drainage channel, 
diverting wastewater directly into the Minamata River (Harada 1995). As a result, 
methylmercury contamination spread throughout the entire Shiranui Sea (Figure 1)  25 
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(Ninomiya et al. 2005; Ninomiya et al. 1995; Yorifuji et al. 2008). Acetaldehyde 
production peaked in 1960 (Yorifuji et al. 2009). Then, acetaldehyde production 
decreased gradually, and the discharge of wastewater was stopped in 1968. Although 
residents voluntarily and temporarily stopped fishing in small Minamata Bay in the late 
1950s, fishing in the Shiranui Sea never been stopped (Tsuda et al. 2009). Therefore, 5 
residents around the Shiranui Sea consumed contaminated fish for more than 10 years 
after first recognition of the disease, and for more than 25 years after the first case in 
1942. 
 In 1971, three years after the discharge of wastewater was stopped, a 
population-based study of neurological signs was conducted by doctors at the 10 
Department of Neuropsychiatry at Kumamoto University School of Medicine. This was 
the largest cross-sectional study ever and has been described in detail elsewhere (Tatetsu 
et al. 1972; Yorifuji et al. 2008). Thus, we describe it only briefly here. One of the 
present authors (M.H.) was a member of that investigation. Neurological signs 
characteristic of methylmercury exposure were mainly examined in residents in the 15 
Minamata, Goshonoura, and Ariake areas (Figure 1). The Minamata area consists of 
three villages along Minamata Bay, and most residents there had been eating 
contaminated fish on a daily basis. The Goshonoura area is on the other side of the 
Shiranui Sea. Residents there also consumed contaminated fish; however, the distance 
from the factory was about 20 km. The Ariake area does not face the Shiranui Sea. It 20 
was investigated as a reference area in 1971. The combined population of the villages in 
each of the three areas, Minamata, Goshonoura, and Ariake, was 1,120, 1,845, and 
1,165 people, respectively. In the Minamata area, 83% (934) of the total population in 
the study area agreed to participate in the 1971 investigation. In the Goshonoura area, 
93% (1,724) of the total population in the study area participated, and in the Ariake area, 25 
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79% (915) of the total population in the study area participated. We excluded residents 
who had past history of cerebrovascular disease (n=18 in the Minamata area, n=12 in 
the Goshonoura area, and n=8 in the Ariake area), organic brain disorder (n=6 in the 
Goshonoura area and n=2 in the Ariake area), and congenital anomaly (n=3 in the 
Minamata area, n=7 in the Goshonoura area, and n=1 in the Ariake area). Consequently, 5 
the final numbers of study participants were 904 in the Minamata area, 1,700 in the 
Goshonoura area and 913 in the Ariake area. 
 
2.2. Measurement of Exposure  
 We adopted residential area as an exposure indicator. In 1960, researchers from 10 
the Kumamoto Prefecture Institute for Health Research investigated total mercury 
content in hair samples of 1,694 residents living on the Coast of the Shiranui Sea, 
including the Minamata and Goshonoura areas (Doi and Matsushima 1996; Matsushima 
and Mizoguchi 1996; Ninomiya et al. 2005). As reported by Ninomiya et al. (2005), in 
Minamata, the median level of mercury was 30.0 μg/g, with an interquartile range of 15 
39.8 μg/g. In Goshonoura, the median was 21.5 μg/g, with an interquartile range of 24.0 
μg/g. In Kumamoto City, the most distant city from Minamata, (see Figure 1), the 
median was 2.1 μg/g, with an interquartile range of 1.3 μg/g. We have no hair mercury 
content information from our study area of Ariake. Because the Ariake Sea is connected 
to the Shiranui Sea by straits, fishermen in the Ariake area sometimes fished in the 20 
Shiranui Sea (Yorifuji et al. 2008). Therefore, subjects in the Ariake area may not be a 
truly unexposed population. However, because like Kumamoto it is on the Ariake Sea 
rather than the Shiranui Sea, we assume that Ariake had a similar low exposure to 
methylmercury. Indeed, it was reported that mercury concentration in cats’ organs on 
the Coast of the Ariake Sea was quite low compared to that of Minamata or other areas 25 
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around Shiranui Sea in 1960 (Kitamura et al. 1960). It was also reported that, even in 
early 1970s, mercury content in fish in the Shiranui Sea was higher than that in Ariake 
Sea (Fujiki and Tajima 1973). Consequently, we considered persons living in the 
Minamata area as having had high exposure, those living in the Goshonoura area as 
having had medium exposure, and those living in the Ariake area as having had low 5 
exposure to methylmercury. 
  
2.3. Measurement of Outcome and Covariates 
 In the present study, we targeted psychiatric symptoms as the health outcome 
examined in the investigation in 1971. The investigation was conducted from August 12, 10 
1971 to September 22, 1971. Although a total of 249 doctors participated in the 
investigation, 36 doctors were mainly responsible for examining the residents. They 
examined the residents of the study areas as a team and visited each study area in order. 
Thus, the doctors examined participants across different areas. Each of these examining 
doctors had at least 3 years of clinical experience and was given special training in the 15 
examination methods before the investigation. Each doctor examined an average of 
10–20 residents a day, and each patient was examined by just one doctor. Informed 
consent was obtained orally. 
 The primary outcome of the 1971 investigation was the presence of 
neurological signs characteristic of methylmercury exposure in residents, with a higher 20 
prevalence of these neurological signs reported in the Minamata area than in the 
reference area of Ariake (Yorifuji et al. 2008). At the time of the examination, 
neurological disorders as well as the following psychiatric symptoms were investigated: 
impairment of intelligence, mood and behavioral dysfunction, dementia, neurotic 
tendencies, depressive disorder, bipolar disorder, and other emotional disturbances such 25 
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as schizophrenic tendencies. Impairment of intelligence was diagnosed based on 
participants’ thinking, understanding, reasoning, calculating ability, and memory 
capacity as well as their knowledge (Inoue 1963). For example, the doctors diagnosed 
the participants as having impairment of intelligence when they had the following 
symptoms: lack of initiative, slow movement or speech, memory disturbance, reduced 5 
thinking, impaired ability to concentrate, reading disorder, loss of judgment, or etc 
(Inoue 1963). Mood and behavioral dysfunction was diagnosed according to whether 
the participants were, for example, apathetic, hypobulic, perseverative, euphoric, 
impatient, shy, difficult to approach, or irritable (Inoue 1963). They did not examine 
participants using psychological batteries or constant form for the interview and they 10 
diagnosed psychiatric symptoms clinically; they thus might not have detected milder 
psychiatric abnormalities. 
 In addition, the examining doctors collected demographic characteristics 
including age, sex, and occupation (full-time, part-time, or non-fisherman).  
 15 
2.4. Statistical Analyses 
 We first calculated prevalence proportions of psychiatric symptoms by 
residential area. We then conducted statistical tests for linear trend, treating the three 
groups as an ordinal variable (1 to 3), and calculated p-values to test whether an 
estimated line deviated from a horizontal line (Selvin 2011). When no participant in the 20 
group had symptom, we treated the group having proportion of zero in the calculation, 
thus we did not disregard it. Subsequently, we estimated the adjusted prevalence odds 
ratios (PORs) of psychiatric symptoms in relation to residential area using a logistic 
regression model, adjusting for age (continuous), sex (binary), and occupation 
(category). When we estimated PORs, we only selected psychiatric symptoms which 25 
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had more than 10 cases in each residential area to avoid unstable statistical models. We 
conducted the same analysis stratifying by dichotomized age category (0–38 years of 
age and 39 years of age or older). We divided the age categories between 38 and 39 so 
that each stratum had the same number of participants. Furthermore, the factory started 
producing acetaldehyde in 1932, 39 years before the survey (George 2001). Therefore, 5 
the younger group was exposed to methylmercury pre- and postnatally; the older group 
was exposed only postnatally.  
 Next, we calculated prevalence proportions of neurological signs characteristic 
of methylmercury poisoning, separated according to psychiatric symptom status 
(impairment of intelligence and mood and behavioral dysfunction) only in the 10 
Minamata area. The selected neurological signs were bilateral sensory disturbance, 
perioral sensory loss, ataxia, dysarthria, tremors, and pathologic reflexes. These signs 
were observed more frequently in the Minamata area than in the Ariake area in a 
previous study (Yorifuji et al. 2008). Bilateral sensory disturbance included glove- and 
stocking-type sensory loss and bilateral diffuse sensory loss. 15 
 Finally, to evaluate the potential non-linear relationships between age and 
psychiatric symptoms in the Minamata area, we drew scatter plots and then modeled 
each indicator as natural splines of age (4 degrees of freedom). Considering the fetal 
Minamata disease patients, we hypothesized that there was at least one peak in young 
generation; therefore we employed the 4 degrees of freedom a priori (Hastie and 20 
Tibshirani 1999). However, our results did not change substantially depending on the 
number of degrees of freedom (6 or 8 degree of freedom), hence we show the results 
obtained from the 4 degrees of freedom. Because the number of participants who were 
older than age 80 was small, we treated them as participants who were 80 years of age. 
As a sensitivity analysis, we conducted the same analysis excluding participants who 25 
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were officially certified as Minamata disease patients by that time (August, 1971). 
 All analyses were conducted by PASW version 18.0J (SPSS Japan Inc.), and 
p-values less than 0.05 (two-sided) were considered significant. Non-linear relationships 
were examined by the package “splines” in the statistical software R version 2.10.1. All 
confidence intervals (CIs) were calculated at the 95% level. 5 
 
3. Results 
 Demographic characteristics of participants are shown in Table 1. The mean 
age and sex ratio were similar in all three areas. Fewer families in the Minamata area 
were supported by fishing. All of the officially certified patients by that time (n = 54) 10 
lived in the Minamata area. Among them, 11 had been diagnosed with fetal Minamata 
disease.  
 The prevalences of impairment of intelligence, mood and behavioral 
dysfunction, and neurotic tendencies were the highest in Minamata (high exposure area). 
The prevalence of dementia was the highest in Ariake (low exposure area; Table 2). 15 
 In Table 3, we show the results of logistic regression models of the main 
analyses for selected psychiatric symptoms (those with cases > 10). Compared with 
persons in the Ariake area, persons in the Minamata area manifested higher PORs for 
impairment of intelligence (POR = 5.2, 95% CI: 3.7–7.3) and mood and behavioral 
dysfunction (POR = 4.4, 95% CI: 2.9–6.7). In the Goshonoura area (medium exposure), 20 
the prevalence were lower for both outcomes. Prevalence of dementia was lower in the 
Goshonoura and Minamata areas; however, the result was not significant in the 
Minamata area. When we stratified by age, the older group in the Minamata area 
manifested higher PORs for impairment of intelligence and mood and behavioral 
dysfunction than did the younger group, although the younger group still manifested 25 
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elevated PORs compared to the Ariake area. These results did not change after we 
excluded those who were officially certified as Minamata disease patients by that time. 
 Participants who had impairment of intelligence or mood and behavioral 
dysfunction had all of the neurological signs more frequently than those without 
psychiatric symptoms (Table 4). For example, about 50% of the participants who 5 
manifested impairment of intelligence had bilateral sensory disturbance compared with 
only 20% of those without impairment of intelligence. Furthermore, the results did not 
change substantially when we excluded those who were officially certified as Minamata 
disease patients. 
 Finally, scatter plots and (non-linear) relationships of age with impairment of 10 
intelligence and mood and behavioral dysfunction are shown in Figures 2a and 2b. 
Although prevalence of both outcomes increased as participants became older, there 
was an additional peak around age 20 in each outcome. This tendency did not change 
after we excluded those who were already officially certified as Minamata disease 
patients (Figures 2c and 2d). 15 
 
4. Discussion 
 We recovered decades-old data from Minamata and neighboring communities 
to evaluate the association between methylmercury exposure and psychiatric symptoms. 
As expected, the data demonstrated higher prevalence proportions of impairment of 20 
intelligence and mood and behavioral dysfunction in the Minamata area, in both the 
older and younger age groups. Furthermore, participants with psychiatric symptoms in 
the Minamata area more often had neurological signs. Finally, there were peaks in the 
prevalence of psychiatric symptoms around age 20 and in older adults in the Minamata 
area. These findings did not change substantially when we excluded those officially 25 
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certified as Minamata disease patients by that time (August 1971). 
 It has already been established that fetal Minamata disease patients manifested 
psychiatric disorders as well as neurological signs and motor disturbance (Harada 1964). 
These various disorders observed among fetal Minamata disease patients were induced 
by diffuse damage to the brain (Minamata Disease Research Group 1966). In contrast, 5 
neurological signs of acquired Minamata disease patients are considered to have been 
induced from damage to granule cells in the cerebellum and cerebral cortex 
(somatosensory, primary visual, and primary auditory areas) due to methylmercury 
intoxication (Ekino et al. 2007). However, pathology studies demonstrated that the 
affected brain lesions resulting from methylmercury in acquired Minamata disease 10 
patients included not only the above-mentioned areas but also the frontal cortex and 
other areas in the temporal or parietal cortex (Minamata Disease Research Group 1966). 
Therefore, given the evidence that disturbance in the frontal, temporal, or parietal cortex 
induces psychiatric disorders (Bradley 2008), it is likely that fetal Minamata disease 
patients as well as acquired Minamata disease patients manifested psychiatric disorders, 15 
which supports the present findings.  
 Moreover, up to now, psychiatric symptoms only among “severe” intrauterine 
exposure cases (i.e., fetal Minamata disease patients) were emphasized in the outbreak 
in Minamata (Harada 1978). However, the present findings suggest that residents who 
had more moderate intrauterine exposure also manifested psychiatric symptoms.  20 
 Furthermore, the finding that participants with psychiatric symptoms had 
neurological signs more frequently in the Minamata area supports evidence that 
psychiatric symptoms were induced by methylmercury exposure. However, it should be 
noted that not all of the participants with psychiatric symptoms had neurological signs. 
This finding may suggest the possibility of earlier plasticity in neurological disorders 25 
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compared to psychiatric dysfunctions because these findings were collected in 1971 
(years after severe exposure in the 1950s and early 1960s). It may also suggest the 
possibility that exposed participants manifested psychiatric symptoms only. 
 The existence of two peaks in prevalence of psychiatric symptoms, at around 
age 20 and in older age adults in the Minamata area, provides an insight regarding 5 
populations vulnerable to psychiatric disorders. This tendency was not observed in other 
areas (Goshonoura and Ariake). The increased prevalence of psychiatric symptoms in 
older adults could be explained by the following. First, methylmercury exerted an even 
more severe effect on degenerating brain cells related to aging. Second, the symptoms 
which were originally induced by methylmercury exposure became more pronounced as 10 
the number of brain cells decreased due to aging. The other generation showing a peak 
of prevalence (around 20 years of age) was the same generation in which fetal 
Minamata disease was diagnosed. Thus, this peak could be explained by 
neurodevelopmental disturbance (Grandjean et al. 1997) due to severe prenatal 
methylmercury exposure in that generation.  15 
 In the present study, compared with participants in the reference area, 
participants in the Minamata area showed a higher prevalence of psychiatric symptoms. 
Prevalence was lower in the Goshonoura area. In other words, we could not find a 
dose-response relationship between residential area and psychiatric symptoms. This 
finding contradicts the previous finding of a clear dose-response relationship between 20 
residential area and neurological signs (Yorifuji et al. 2008). In that neurological study, 
the highest prevalence of neurological signs was observed in the Minamata area, 
although the prevalence in the Goshonoura area was also higher than in the Ariake area. 
This contradiction, i.e. lack of a dose-response relationship with psychiatric symptoms, 
may have resulted from the following two possible scenarios: First, although there was 25 
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a dose-response relationship in reality, we could not detect it and only found a spurious 
association due to the flawed study design. For example, the examining doctors could 
not spend plenty of time (e.g., 30-60 minutes) and did not examine participants using 
stricter criteria or psychological batteries; they thus could not have detected milder 
psychiatric abnormalities. Moreover, there might be other risk factors (potential 5 
confounders) related to psychiatric symptoms between areas. Second, this observed 
finding, i.e., lack of dose-response relationship, might show the true relationship. For 
example, threshold of psychiatric symptoms might be higher than that of each 
neurological sign characteristics of methylmercury poisoning. Moreover, the severe and 
longer effects in the Minamata area may have made it possible to detect effects of 10 
methylmercury poisoning on psychiatric symptoms. Indeed, although the factory had 
discharged methylmercury since 1932, the pollution throughout the entire Shiranui Sea, 
including the Goshonoura area, started to be identified after the factory diverted 
wastewater directly into the Minamata River in 1958 (Harada 1995). Although we could 
not verify which scenario was true, these situations can not explain the observed effects 15 
in the Minamata area.  
 In this study, the validity of residential area as an exposure indicator in the 
main analyses should be examined. Because fishing in the Shiranui Sea had never 
stopped, the residents of that coastal area (Minamata and Goshoura) were presumably 
exposed to methylmercury at least until 1968. Furthermore, even in 1996, mercury was 20 
still deposited at the bottom of the Shiranui Sea, making a gradient from the east (highly 
deposited) to the west (Tomiyasu et al. 2000). Even the deposited mercury in the west 
exceeded the background levels (Tomiyasu et al. 2000). Therefore, residential area as an 
indicator of long-term exposure to methylmercury appears to be justified.  
 Differential disease misclassification is possible because many doctors knew of 25 
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the famous outbreak in Minamata. However, given that every examining doctor 
belonged to the neuropsychiatry department at a school of medicine, had at least 3 years 
of clinical experience, and was trained in the methodological examination by a 
supervisor before the investigation, the validity of diagnosis should have been 
maximized. Furthermore, the association between methylmercury exposure and 5 
psychiatric symptoms was not paid much attention at that time, especially in adults, 
compared to the association of exposure with neurological signs. Finally, even if there 
was differential exposure misclassification, the bias could have induced neither such 
large effects observed in the present study nor differential distribution of prevalence 
among age groups. Although we could not adjust for the examiner effect, as described, 10 
every doctor belonged to the same department, was trained before the investigation, and 
examined participants across different areas, therefore the method of diagnosis should 
have been standardized and the differences in diagnosis among the study areas should 
have been minimized. 
 Because the participation proportion was very high in all areas, selection bias 15 
should have been negligible. However, severely affected cases died in the 1950s, and 
there was a population outflow due to economic problems including shortage of jobs 
and low income in Minamata. Therefore, selection bias resulting from these missing 
cases may have caused an underestimate of the true magnitude of the effects. 
 In conclusion, the present study suggests a relationship between prenatal or 20 
postnatal exposure to methylmercury and psychiatric symptoms even after excluding 
residents who had been officially certified as Minamata disease patients by that time. 
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Figure captions 
Figure 1. Map of the study area. 
 
Figure 2a. A scatter plot and non-linear relationship between age and proportion of 
impairment of intelligence. A curve of natural spline represented by a thick black line (4 5 
degrees of freedom) and its 95% confidence interval (dotted black line) are shown. 
 
Figure 2b. A scatter plot and non-linear relationship between age and proportion of 
mood and behavioral dysfunction. A curve of natural spline represented by a thick black 
line (4 degrees of freedom) and its 95% confidence interval (dotted black line) are 10 
shown. 
 
Figure 2c. A scatter plot and non-linear relationship between age and proportion of 
impairment of intelligence after excluding officially certified Minamata disease patients. 
A curve of natural spline represented by a thick black line (4 degrees of freedom) and its 15 
95% confidence interval (dotted black line) are shown. 
 
Figure 2d. A scatter plot and non-linear relationship between age and proportion of 
mood and behavioral dysfunction after excluding officially certified Minamata disease 
patients. A curve of natural spline represented by a thick black line (4 degrees of 20 
freedom) and its 95% confidence interval (dotted black line) are shown. 
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Table 1. Demographic characteristics of participants in the 1971 survey by study area   
    Low Exposure   Medium Exposure   High Exposure 
  Ariake area  Goshonoura area  Minamata area 
    n=904   n=1,700   n=913 
Mean Age, y; (SD) 37 (24)  36 (24)  38 (22) 
       
Sex; n (%)      
 Women 504 (56)  908 (53)  515 (56) 
       
Familial Occupational Status; n  (%)      
 Fishermen 319 (35)  732 (43)  201 (22) 
 Part-time fishermen 247 (27)  196 (12)  190 (21) 
 Nonfishermen 336 (37)  761 (45)  484 (53) 
 Unknown   2 (0.2)   11 (0.6)  38 (4.2) 
       
Officially certified patients; n 0  0  54 
       
Diagnosed with congenital Minamata 
disease patients among certified patients; n 
0 
 
0 
 
11 
  
       
Total number of subjects and percentages may not sum due to missing data and rounding. 
SD, standard deviation. 
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Table 2. Number and prevalence proportion of psychiatric symptoms by study area 
    Low Exposure Medium Exposure High Exposure 
P-value 
for trend 
  Ariake area Goshonoura area Minamata area 
    n=904 n=1,700 n=913 
       
Impairment of intelligence; n (%)  50 (5.5) 55 (3.2) 186 (20.4) 0.00  
      
Mood and behavioral dysfunction; n (%)  30 (3.3) 35 (2.1) 114 (12.5) 0.00  
      
Dementia; n (%)  20 (2.2) 13 (0.8) 10 (1.1) 0.03  
      
Neurotic tendency; n (%)  4 (0.4) 2 (0.1) 31 (3.4) 0.00  
      
Depressive disorder; n (%)  5 (0.6) 3 (0.2) 4 (0.4) 0.68  
      
Bipolar disorder; n (%)  4 (0.4) 5 (0.3) 0 (0) 0.06  
      
Other emotional disorder; n (%)  5 (0.6) 13 (0.8) 9 (1.0) 0.29  
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Table 3. Adjusted associations (POR and 95% CI) of residential areas with selected psychiatric symptoms 
      Low Exposurea   Medium Exposure   High Exposure 
   Ariake area  Goshonoura area  Minamata area 
      n=904   n=1,700   n=913 
All participantsb      
  Impairment of intelligence 1.0   0.6 (0.4 - 0.9)  5.2 (3.7 - 7.3) 
  Mood and behavioral dysfunction 1.0   0.6 (0.4 - 1.0)  4.4 (2.9 - 6.7) 
  Dementia 1.0   0.3 (0.2 - 0.7)  0.5 (0.2 - 1.2) 
Stratified by age categoryb      
 Age: 0-38 (ys)       
  Impairment of intelligence 1.0   0.7 (0.4 - 1.2)  2.8 (1.7 - 4.6) 
  Mood and behavioral dysfunction 1.0   0.8 (0.4 - 1.5)  1.8 (1.0 - 3.5) 
  Dementia 1.0   0.3 (0.1 - 0.8)  0.5 (0.2 - 1.4) 
 Age: ≥39 (ys)       
  Impairment of intelligence 1.0   0.4 (0.2 - 0.8)  9.9 (6.1 - 16) 
  Mood and behavioral dysfunction 1.0   0.4 (0.2 - 1.0)  8.3 (4.6 - 15.1) 
  Dementia 1.0   0.3 (0.2 - 0.7)  0.5 (0.2 - 1.2) 
aReference category 
bPrevalence odds ratios were estimated compared with Ariake area and were adjusted for age, sex, and occupation. 
POR, prevalence odds ratio; CI, confidence interval  
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Table 4. Number and prevalence proportion of neurological signs by psychiatric symptom status of 
participants living in the Minamata area (n = 913) 
 Impairment of intelligence Mood and behavioral dysfunction 
  
Negative 
(n=727) 
Positive 
(n=186) 
Negative 
(n=799) 
Positive 
(n=114) 
Bilateral sensory disturbancea; n 
(%) 
158 (21.9) 96 (52.2) 195 (24.7) 59 (51.8) 
     
Perioral sensory loss; n (%) 53 (7.3) 44 (23.8) 69 (8.7) 28 (24.6) 
     
Ataxia; n (%) 151 (20.8) 121 (65.1) 200 (25) 72 (63.2) 
     
Dysarthria; n (%) 85 (11.7) 95 (51.1) 126 (15.8) 54 (47.4) 
     
Tremors; n (%) 79 (10.9) 47 (25.3) 97 (12.1) 29 (25.4) 
     
Pathologic reflexes; n (%) 32 (4.4) 18 (9.7) 42 (5.3) 8 (7) 
     
aBilateral sensory disturbance includes glove- and stocking-type sensory loss and bilateral diffuse sensory loss. 
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